Mucosal distribution of infliximab in patients with Crohn's disease (CD).

被引：0
作者：
Geboes, K
Dalle, I
Baert, F
D'Haens, G
Cornillie, F
Rutgeerts, P
机构：
[1] Univ Hosp Sint Raphael, Louvain, Belgium
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] Centocor Inc, Leiden, Netherlands
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1664
引用
收藏
页码：A322 / A322
页数：1
相关论文
共 50 条
  • [41] A novel clinical radiomics nomogram at baseline to predict mucosal healing in Crohn's disease patients treated with infliximab
    Zhu, Chao
    Hu, Jing
    Wang, Xia
    Li, Cuiping
    Gao, Yankun
    Li, Jianying
    Ge, Yaqiong
    Wu, Xingwang
    EUROPEAN RADIOLOGY, 2022, 32 (10) : 6628 - 6636
  • [42] Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab
    Appleton, Laura
    Day, Andrew S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (06) : 1080 - 1081
  • [43] Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab
    Laharie, D.
    Reffet, A.
    Belleannee, G.
    Chabrun, E.
    Subtil, C.
    Razaire, S.
    Capdepont, M.
    de Ledinghen, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (06) : 714 - 721
  • [44] Mucosal Healing With Methotrexate in Crohn's Disease: A Prospective Comparative Study With Azathioprine and Infliximab
    Laharie, David
    Reffet, Armel
    Chabrun, Edouard
    Subtil, Clement
    Razaire, Sylvie
    de Ledinghen, Victor
    GASTROENTEROLOGY, 2010, 138 (05) : S689 - S690
  • [45] Decreased mucosal lymphocyte proliferation following treatment with Infliximab in Crohn's disease.
    Geboes, K
    Baert, F
    D'Haens, GR
    Cornillie, F
    Rutgeerts, PJ
    GASTROENTEROLOGY, 2000, 118 (04) : A344 - A344
  • [46] Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn's Disease
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Lee, Soo-Youn
    Baek, Sun-Young
    Sohn, Insuk
    Choe, Byung-Ho
    Lee, Hae Jeong
    Choe, Yon Ho
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (02) : 189 - 197
  • [47] Discussion on predictors of response to infliximab in patients with Crohn's disease
    Hommes, D
    GASTROENTEROLOGY, 2003, 124 (07) : 2002 - 2003
  • [48] Infliximab Treatment for Anal Fistula in Patients with Crohn's Disease
    Higashi, Daijiro
    Futami, Kitaro
    Egawa, Yuji
    Hirano, Kennji
    Tomiyasu, Takashige
    Ishibashi, Yukiko
    Simomura, Tamotsu
    Nii, Kaori
    Kuroki, Hirosuke
    Maekawa, Takafumi
    Ono, Yoichiro
    Matsui, Toshiyuki
    ANTICANCER RESEARCH, 2009, 29 (03) : 927 - 933
  • [49] Infliximab therapy and LFT abnormalities in patients with Crohn's disease
    Blum, Eric
    Katz, Jeffry
    GASTROENTEROLOGY, 2006, 130 (04) : A659 - A660
  • [50] Discontinuation of infliximab in patients with Crohn's disease on combination therapy
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (03) : 131 - 131
12345